We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02009579
Recruitment Status : Active, not recruiting
First Posted : December 12, 2013
Last Update Posted : March 2, 2022
Sponsor:
Collaborators:
Grupo Español de Investigación en Cáncer de Ovario
Mario Negri Gynecologic Oncology group (MaNGO)
Multicenter Italian Trials in Ovarian Cancer (MITO)
North Eastern German Society of Gynaecological Oncology
Information provided by (Responsible Party):
Belgian Gynaecological Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 2021
Estimated Study Completion Date : October 2023